January 24, 2017 2:35 AM ET

Healthcare Providers and Services

Company Overview of Acadia Healthcare Company, Inc.

Company Overview

Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico. Its acute inpatient psychiatric facilities offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities include residential recovery facilities, eating disorder facilities, and comprehensive treatment centers providing a comprehensive continuum of care for adults with addictive disorders and co-occurring men...

6100 Tower Circle

Suite 1000

Franklin, TN 37067

United States

Founded in 2005

17,800 Employees

Phone:

615-861-6000

Fax:

615-261-9685

Key Executives for Acadia Healthcare Company, Inc.

Chairman and Chief Executive Officer
Age: 63
Total Annual Compensation: $1.0M
President
Age: 50
Total Annual Compensation: $550.0K
Chief Financial Officer, Chief Accounting Officer and Controller
Age: 36
Total Annual Compensation: $480.0K
Chief Operating Officer
Age: 63
Total Annual Compensation: $600.0K
Executive Vice President, General Counsel and Secretary
Age: 49
Total Annual Compensation: $500.0K
Compensation as of Fiscal Year 2015.

Acadia Healthcare Company, Inc. Key Developments

Court Certifies Class in PHC, Inc. Shareholder Litigation Scheduled to Begin on February 27, 2017

All Class A shareholders of PHC, Inc. who abstained from voting or voted against the 2011 merger of PHC with Acadia Healthcare Company, Inc. (Acadia) and held their shares immediately prior to and whose shares were converted to Acadia shares after the effective merger date. The United States District Court, District of Massachusetts has certified In re: PHC, Inc. Shareholder Litigation, C.A. No. 11-11049-PBS as a class action. A trial against certain former PHC directors, Acadia and Acadia Merger Sub, LLC (the 'Defendants'), has been scheduled to begin on February 27, 2017. This lawsuit alleges Defendants violated fiduciary duties owed to the Class by causing the Merger to be effected on unfair terms and pursuant to an unfair process.

Acadia Healthcare Company, Inc. Presents at 35th Annual JP Morgan Healthcare Conference, Jan-09-2017 02:30 PM

Acadia Healthcare Company, Inc. Presents at 35th Annual JP Morgan Healthcare Conference, Jan-09-2017 02:30 PM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, CA 94102, United States. Speakers: Joey A. Jacobs, Chairman and Chief Executive Officer.

Acadia Healthcare Company, Inc. Announces Unaudited Consolidated Earnings Results for Third Quarter and Nine Months Ended Sept. 30, 2016; Revises Earnings Guidance for the Fourth Quarter and Year 2016

Acadia Healthcare Company, Inc. announced unaudited consolidated earnings results for third quarter and nine months ended Sept. 30, 2016. For the quarter, the company reported revenue of $734,665,000, loss from continuing operations before income taxes of $115,814,000, loss from continuing operations of $118,210,000, net loss of $118,210,000, net loss attributable to Acadia Healthcare Company, Inc. of $117,808,000, diluted loss from continuing operations per share of $1.36, diluted net loss per share of $1.36, lbitda of $30,553,000, adjusted ebitda of $155,838,000, adjusted income from continuing operations attributable to Acadia Healthcare Company, Inc. of $49,918,000, adjusted income from continuing operations attributable to Acadia Healthcare Company, Inc. per diluted share of $0.58 compared to the revenue of $479,730,000, income from continuing operations before income taxes of $41,675,000, income from continuing operations of $29,006,000, net income of $29,086,000, net income attributable to Acadia Healthcare Company, Inc. of $29,550,000, diluted income from continuing operations per share of $0.42, diluted net income per share of $0.42, ebitda of $86,302,000, adjusted ebitda of $108,468,000, adjusted income from continuing operations attributable to Acadia Healthcare Company, Inc. of $43,890,000, adjusted income from continuing operations attributable to Acadia Healthcare Company, Inc. per diluted share of $0.62 for the same quarter a year ago. For the nine months, the company reported revenue of $2,108,026,000, loss from continuing operations before income taxes of $9,483,000, loss from continuing operations of $37,250,000, net loss of $37,250,000, net loss attributable to Acadia Healthcare Company, Inc. of $35,675,000, diluted loss from continuing operations per share of $0.42, diluted net loss per share of $0.42, ebitda of $226,977,000, adjusted ebitda of $459,076,000, adjusted income from continuing operations attributable to Acadia Healthcare Company, Inc. of $158,904,000, adjusted income from continuing operations attributable to Acadia Healthcare Company, Inc. per diluted share of $1.86, net cash provided by operating activities of $259,657,000, cash paid for capital expenditures of $249,961,000 compared to the revenue of $1,299,173,000, income from continuing operations before income taxes of $112,235,000, income from continuing operations of $77,441,000, net income of $77,524,000, net income attributable to Acadia Healthcare Company, Inc. of $77,988,000, diluted income from continuing operations per share of $1.15, diluted net income per share of $1.15, ebitda of $235,087,000, adjusted ebitda of $292,983,000, adjusted income from continuing operations attributable to Acadia Healthcare Company, Inc. of $110,461,000, adjusted income from continuing operations attributable to Acadia Healthcare Company, Inc. per diluted share of $1.64, net cash provided by operating activities of $142,085,000, cash paid for capital expenditures of $200,841,000 for the same period a year ago. Based on company’s results for the third quarter and outlook for the fourth quarter, including the impact of the exchange rate and the planned U.K. divestiture transaction, the Company revised its guidance for 2016 adjusted earnings per diluted share to a range of $2.41 to $2.42. The company’s guidance also assumes a tax rate of 22% For the fourth quarter 2016, the company adjusted earnings per diluted share for the fourth quarter is projected to be in a range of $0.55 to $0.56 and assumes an exchange rate of $1.22 per British Pound Sterling. The fourth quarter guidance was negatively impacted by approximately $0.03 to reflect the lower exchange rate and $0.02 for the net impact of the divestiture transaction, which is expected to close on November 30, 2016. The company’s guidance also assumes a tax rate of 22%. The company’s guidance does not include the impact of any future acquisitions or transaction-related expenses.

Similar Private Companies By Industry

Company Name Region
@ Home Medical, Inc. United States
@home approach, llc United States
@Home Care United States
1011 E. Pecan Grove Road, LLC United States
1104 Welsh Road Operations LLC United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
August 5, 2016
Highland Hospital Association Inc.
Merger/Acquisition
May 3, 2016
Polaris Hospital Company LLC
Merger/Acquisition
February 16, 2016
Five Inpatient Facilities With 200 Beds and 19 CTCs
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Acadia Healthcare Company, Inc., please visit www.acadiahealthcare.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.